Highland Park, IL, United States of America

Kathleen Raye


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kathleen Raye: Innovator in Antibacterial and Antineoplastic Compounds

Introduction

Kathleen Raye is a notable inventor based in Highland Park, IL (US). She has made significant contributions to the field of chemistry, particularly in the development of compounds with potential antibacterial and antineoplastic activity. Her work is recognized for its innovative approach to creating useful intermediates in medicinal chemistry.

Latest Patents

Kathleen Raye holds a patent for her invention titled "Benzo[5.6]pyrano[2.3.4-ij]quinolizine and benzo[5.6]thiopyrano[2.3.4-ij]quinolizine compounds." This patent includes compounds characterized by specific formulas where A can be sulfur or oxygen, and various groups are selected from a range of chemical structures. The patent highlights the utility of these compounds as intermediates and their potential therapeutic applications.

Career Highlights

Kathleen Raye is associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. Her work at Abbott has allowed her to focus on innovative research and development in the pharmaceutical field. With her expertise, she has contributed to advancements that may lead to new treatments for various diseases.

Collaborations

Kathleen has collaborated with esteemed colleagues such as Daniel T. Chu and Qun Li. These collaborations have fostered a productive environment for research and innovation, enhancing the impact of their collective work in the field.

Conclusion

Kathleen Raye's contributions to the field of chemistry and her innovative patents demonstrate her commitment to advancing medical science. Her work continues to inspire future research and development in antibacterial and antineoplastic compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…